Bora Pharmaceuticals Co., Ltd. (TPE:6472)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Sales Operations Department	14.77B	15.31B	9.25B	5.76B	532.39M
Sales Operations Department Growth	-3.54%	65.50%	60.59%	982.02%	6.41%
Adjustments and Eliminations	-5.44B	-5.61B	-761.19M	-304.00M	-135.84M
CDMO Operations Department	8.84B	6.92B	5.44B	4.84B	4.42B
CDMO Operations Department Growth	27.72%	27.28%	12.44%	9.43%	236.74%
Other Operations Department	845.31M	802.33M	273.38M	202.85M	85.09M
Other Operations Department Growth	5.36%	193.49%	34.77%	138.41%	111.69%
Total	19.01B	17.43B	14.20B	10.49B	4.90B
Total Growth	9.11%	22.72%	35.31%	114.18%	172.28%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Europe	2.61B	2.13B	2.08B	3.13B	3.39B
Europe Growth	22.87%	2.28%	-33.51%	-7.78%	1480.09%
United States	14.68B	13.62B	10.96B	6.51B	861.59M
United States Growth	7.79%	24.34%	68.17%	656.10%	-11.08%
Taiwan	1.29B	1.43B	1.05B	850.69M	645.02M
Taiwan Growth	-9.71%	35.73%	23.81%	31.88%	4.73%
Other	425.14M	246.83M	110.93M	-	-
Other Growth	72.24%	122.51%	-	-	-
Total	19.01B	17.43B	14.20B	10.49B	4.90B
Total Growth	9.11%	22.72%	35.31%	114.18%	172.28%

Source: S&P Global Market Intelligence.